GGrantIndex
Sort

46,585 grants matching heart failure

Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity

$516,606
Jasper Smits · University Of Texas At Austin · R01 · FY2024 · CA

Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine

$516,595
Ioannis Karakikes · Stanford University · R01 · FY2025 · HL

Quantitative mass spectrometry for comprehending epigenetic mechanisms in a new underlying neurological developmental disorder

$516,556
Benjamin A Garcia · Washington University · R01 · FY2025 · HD

Analysis of ABCA Transporter Function in Homologous Recombinant Mice

$516,541
Mason W Freeman · Massachusetts General Hospital · R24 · FY2008 · RR

Heart Failure Clinical Research Network - RCC

$516,532
Christopher M O'Connor · Duke University · U01 · FY2009 · HL

Immune dysfunction and pulmonary hypertension in primate model of HIV infection

$516,531
Karen A Norris · University Of Pittsburgh At Pittsburgh · R56 · FY2014 · HL

JACKSON HEART STUDY--TRAINING CENTER

$516,446
Tougaloo College · N01 · FY2000 · HC

NICHD Health Research Board Of Ireland Neural Tube Defects Study

$516,443
James Mills · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD

ADULT STEM CELL MINIMALLY INVASIVE BONE MARROW HARVESTER

$516,400
Daniel Lewis Kraft · Regenmed Systems, Inc. · R44 · FY2011 · GM

Project 3: Control of cardiac transcription by MEF2 and myocardin

$516,335
Brian L Black · J. David Gladstone Institutes · P01 · FY2020 · HL

Calcineurin compartmentation and regulation of pathological cardiac remodeling

$516,295
Michael S Kapiloff · Stanford University · R01 · FY2024 · HL

Development of Novel RhoA Nitration Inhibitory Peptides for the Treatment of Acute Lung Injury

$516,250
Stephen M Black · Florida International University · R61 · FY2025 · HL

Cardioprotection with mTOR Inhibition

$516,135
Rakesh C. Kukreja · Virginia Commonwealth University · R01 · FY2019 · HL

Cardioprotection with mTOR Inhibition

$516,135
Rakesh C. Kukreja · Virginia Commonwealth University · R01 · FY2017 · HL

Cardioprotection with mTOR Inhibition

$516,135
Rakesh C. Kukreja · Virginia Commonwealth University · R01 · FY2016 · HL

Role of SR-mitochondria interplay in calcium-dependent arrhythmias

$516,131
Bin Liu · University Of Florida · R01 · FY2024 · HL

Inhibition of Cardiac Device Induced Cellular Dysfunction in Pigs

$516,118
Rekha Bansal · Novelmed Therapeutics, Inc. · R44 · FY2010 · HL

Project 3: Endothelial and smooth muscle cell programs for pulmonary arterial hypertension

$516,060
Marlene Rabinovitch · Stanford University · P01 · FY2025 · HL

Impact of Emerging Health Insurance Designs on Diabetes Complications

$516,045
James Franklin Wharam · Harvard Pilgrim Health Care, Inc. · R01 · FY2014 · DK

CAREER: GPU-Accelerated Framework for Integrated Modeling and Biomechanics Simulations of Cardiac Systems

$516,000
Adarsh Krishnamurthy · Iowa State University · · FY2018 · CSE

Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery

$515,993
Amanda A Fox · Ut Southwestern Medical Center · R01 · FY2023 · HL

SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)

$515,991
Douglas Lowell Mann · Washington University · U10 · FY2012 · HL

Myocardial Viability and Remodeling in the OAT

$515,980
James E Udelson · Tufts Medical Center · R01 · FY2006 · HL

Hemostasis System in Acute Inflammation-Sepsis

$515,967
Francis J Castellino · University Of Notre Dame · P01 · FY2007 · HL

Autoimmune Determinants of Human Cardiac Myosin

$515,955
Madeleine W. Cunningham · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2013 · HL